Psychopharmacology

, Volume 118, Issue 2, pp 178–182 | Cite as

Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety

  • G. A. Kennett
  • F. Bailey
  • D. C. Piper
  • T. P. Blackburn
Original Investigation

Abstract

SB 200646A is the first selective 5-HT2C/5-HT2B receptor antagonist and has previously been observed to have anxiolytic-like properties in the rat social interaction test. In the present study the effects of the compound in two conflict models of anxiety, the rat Geller-Seifter and marmoset conflict test, were examined. In the rat Geller-Seifter test, suppressed responding was increased by all doses of SB 200646A between 5 and 40 mg/kg PO when given 1 h pretest. Unsuppressed responding was slightly increased only at 10 mg/kg PO. Suppressed responding was also increased by the benzodiazepine anxiolytic, chlordiazepoxide, at 1, 2.5 and 5 mg/kg PO 1 h pretest. Unsuppressed responding was modestly increased by chlordiazepoxide only at 5 mg/kg PO. In the marmoset conflict test marmosets were trained to lever press for a palatable food reward. Lever pressing was subsequently suppressed by air puffs. In this procedure suppressed responding was increased by both the benzodiazepine anxiolytic diazepam at 2 and 5 mg/kg PO and SB 200646A after 10 and 20 mg/kg PO. Both treatments caused small increases in unsuppressed responding at 2 and 20 mg/kg PO respectively. Taken together with the previous effects of SB 200646A in the rat social interaction test, this is compelling evidence that 5-HT2C/2B receptor antagonists may possess anxiolytic properties.

Key words

SB 200646A 5-HT2C 5-HT2B Anxiety Conflict models 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beckett SRG, Marshall PW, Marsden CA (1992) Intraperiaqueductal grey administration of mCPP potentiates a chemically-induced defence response. Brit J Pharmacol 107 [Suppl 1]:8PGoogle Scholar
  2. Brown AM, Patch TL, Kaumann AJ (1991) The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus. Br J Pharmacol 104:45–48Google Scholar
  3. Bucheit KH, Engel G, Hagenbach A, Hoyer D, Kalkman HO, Seiler MP (1986) The rat isolated stomach fundus strip, a model of 5-HT1C receptors. Br J Pharmacol 88:367PGoogle Scholar
  4. Clineschmidt BV, Reiss DR, Pettibone DJ, Robinson JL (1985) Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J Pharmacol Exp Ther 235:696–708Google Scholar
  5. File SE, Hyde JRG (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19–24Google Scholar
  6. Foquet M, Nguyen H, Le H, Lubbert H (1992) Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes. Neuroreport 3:345–348Google Scholar
  7. Forbes IT, Kennett GA, Gadre A, Ham P, Hayward CJ, Martin RT, Thompson M, Wood MD, Baxter GS, Glen A, Murphy OE, Stewart B, Blackburn TP (1993)N-(1-Methyl-5-indolyl)-N′-(3-pyridyl)urea hydrochloride: the first selective 5-HT1Creceptor antagonist. J Med Chem 36:1104–1107Google Scholar
  8. Gleeson S, Ahlers ST, Mansbach RS, Roust JM, Barrett JE (1989) Behavioural studies with anxiolytic drugs. IV. Effects on punished responding of drugs interacting with serotonin receptor subtypes. J Pharmacol Exp Ther 250:809–817Google Scholar
  9. Griebel G, Misslin R, Pawlowski M, Vogel E (1991)m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice. Neuroreport 2:627–629Google Scholar
  10. Higgins GA, Jones BJ, Oakley NR, Tyers MB (1991) Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists. Psychopharmacology 104:545–551Google Scholar
  11. Hoffman BJ, Mezey E (1989) Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett 247:453–462Google Scholar
  12. Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for the 5-HT receptors. Trends Pharmacol Sci 14:233–236Google Scholar
  13. Kalen P, Rosengren E, Lindvall O, Bjorklund A (1989) Hippocampal noradrenaline and serotonin release over 24 hours as measured by the dialysis technique in freely moving rats: correlation to behavioural activity state, effect of handling and tail pinch. Eur J Neurosci 1:181–186Google Scholar
  14. Kalus O, Kahn RS, Wetzler S, Asnis GM, Van Praag HM (1990) Hypersensitivity tom-chlorophenylpieperazine in a subject with subclinical panic attacks. Biol Psychiat 28:1053–1057Google Scholar
  15. Kennett GA (1992) 5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction test. Psychopharmacology 107:397–402Google Scholar
  16. Kennett GA (1993) 5-HT1C receptors and their therapeutic relevance. Curr Opin Invest Drugs 2:371–362Google Scholar
  17. Kennett GA, Blackburn TP (1990) Anxiolytic-like actions of BRL 46470-a novel 5-HT3 receptor antagonist. J Psychopharmacol 4:2Google Scholar
  18. Kennett GA, Curzon G (1991) Potencies of antagonists indicate that 5-HT1C receptors mediate 1–3(chlorophenyl) piperazineinduced hypophagia. Brit J Pharmacol 103:2016–2020Google Scholar
  19. Kennett GA, Whitton P, Shah K, Curzon G (1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptro antagonists. Eur J Pharmacol 164:445–454Google Scholar
  20. Kennett GA, Pittaway K, Blackburn TP (1994a) Evidence that 5-HT2C receptor antagonists are anxiolytic in the Geller-Seifter model of anxiety. Psychopharmacology 114:90–96Google Scholar
  21. Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP (1994b) In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist. Brit J Pharmacol, 111:797–802Google Scholar
  22. Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M (1992) Molecular cloning, functional expression, and characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. Mol Pharmacol 42:547–557Google Scholar
  23. Loric S, Launay J-M, Colas J-F, Maroteaux L (1992) New mouse 5-HT2-like receptor: expression in brain, heart and intestine. FEBS Lett 312:203–207Google Scholar
  24. Mengod G, Nguyen H, Le H, Waeber C, Lubbert H, Palacios JM (1990) The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35:577–591Google Scholar
  25. Molineaux SM, Jessell TM, Axel R, Julius D (1989) 5-HT1C receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci USA 86:6793–6797Google Scholar
  26. Piggott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, ZoharKadouch RC, Murphy DL (1991) Metergoline blocks the behavioural and neuroendocrine effects of oral mCPP in obsessive-compulsive disorder. Biol Psychiatry 29:418–426Google Scholar
  27. Piper DC (1988) A new quantitative reward-based test for anxiolytic drug effects in marmosets. Psychopharmacolgy 96:S171Google Scholar
  28. Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2C receptors. Mol Brain Res 23:163–178Google Scholar
  29. Pranzatelli MR (1990) Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioural effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI). Neurosci Lett 115:74–80Google Scholar
  30. Rezazadeh SM, Prather PL, Lal H (1993) Sensitisation to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol. Alcohol 10:281–283Google Scholar
  31. Schmuck K, Ullmer C, Engels P, Lubbert H (1994) Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS Lett 342:85–90Google Scholar
  32. Schoeffter P, Hoyer D (1989) Interactions of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C, and 5-HT1D receptors: do discriminatory 5-HT2B receptor ligands exist? Naunyn Schmiedebergs Arch Pharmacol 339:675–683Google Scholar
  33. Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico CD, Henninger GR, Charney DS (1991) Effects of ritanserin on the behavioural neuroendocrine and cardiovascular responses to meta chlorophenylpiperazine in healthy subjects. Psychiatry Res 38:227–236Google Scholar
  34. Shimzu N, Take S, Hori T, Oomura Y (1992) In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats. Brain Res Bull 28:727–734Google Scholar
  35. Whitton P, Curzon G (1990) Anxiogenic-like effect of infusing 1-(3-chlorophenyl)piperazine (mCPP) into the hippocampus. Psychopharmacology 100:138–140Google Scholar
  36. Wright IK, Upton N, Marsden CA (1992) Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology 109:338–346Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • G. A. Kennett
    • 1
  • F. Bailey
    • 1
  • D. C. Piper
    • 1
  • T. P. Blackburn
    • 1
  1. 1.SmithKline BeechamHarlowUK

Personalised recommendations